Catalyst Wire Dossier Catalyst Wire Dossier

Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D)

· Abbott Medical Devices
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D), covering 2019-02-27 to 2019-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study [NA]

See pricing